Our products and pipeline
Our technologies
News & Media
GenSight Biologics Reports Full Year 2019 Financial Results and provides an Outlook on 2020
GenSight Biologics announces presentation of bilateral visual recovery from GS010 (LUMEVOQ™) Phase III trials at the 46th annual meeting of NANOS
GenSight Biologics Reports its Cash Position as of December 31, 2019 and Provides Operational Update
GENSIGHT BIOLOGICS S.A.
74, rue du Faubourg Saint-Antoine
75012 Paris
FRANCE
74, rue du Faubourg Saint-Antoine
75012 Paris
FRANCE
+33 1 76 21 72 20
Contact us